What question did this study set out to answer?

To investigate the transmission of FKS1 mutations in Candida auris in Orange County, CA, during an outbreak.

January 14, 2026Open Forum Infectious Diseases0 citationsOpen Access

Transmission of Candida auris FKS1 Mutations in Orange County, CA

JBJennifer BrownOrange County Healthcare Agency MLMi Nguyen‐Tra LeOrange County Healthcare Agency DTDenise TirolOrange County Healthcare Agency

Key Points

To investigate the transmission of FKS1 mutations in Candida auris in Orange County, CA, during an outbreak.
Identified 3,366 C. auris cases from Feb 2019 - Mar 2025 in Orange County
Conducted whole genome sequencing (WGS) on 601 isolates for FKS1 mutation identification
Performed antifungal susceptibility testing (AFST) on 988 isolates
Supported cluster identification and SNP analysis with Theiagen Genomics and Nevada State Public Health Lab
Gathered epidemiological data on patient movement and antifungal treatment.
Detected FKS1 mutations in 4 (1%) Clade III and 19 (10%) Clade I isolates
Identified eight distinct FKS1 mutations
Clustered nine cases with a single FKS1 mutation in the Clade I tree
Noted person-to-person transmission within high-risk healthcare facilities
Emphasized the integration of public health investigation with WGS for understanding transmission.

Abstract

Abstract Background Candida auris (C. auris) is a potentially multidrug-resistant yeast that can cause severe infections in high-risk patient care populations and is endemic in Orange County (OC). U.S. isolates remain largely susceptible to echinocandins, the first-line therapy for most invasive infections, though echinocandin resistance (Ech-R) is emerging. FKS1 mutations associated with Ech-R have been thought to be primarily driven by antifungal exposure, though a recent study indicated apparent transmission in U. S. healthcare settings (MMWR). We investigated a cluster of 9 OC C. auris cases with FKS1 mutations identified by whole genome sequencing (WGS) analysis. Methods 3,366 OC cases were identified from Feb 2019 - Mar 2025. A total of 601 isolates from 549 cases (16%) underwent WGS at the OC Public Health Lab for clade and FKS1 mutation identification. 988 isolates from 688 cases (20%) underwent Antifungal Susceptibility Testing (AFST) at the Antimicrobial Resistance Laboratory Network (ARLN). Cluster identification, WGS single nucleotide polymorphism (SNP) analysis and phylogenetic tree development were supported by Theiagen Genomics and Nevada State Public Health Lab. Epidemiological data including healthcare facility movement, patient exposure, and antifungal treatment was obtained for all cases with FKS1 mutations. Results FKS1 mutations were detected in 4 (1%) Clade III and 19 (10%) Clade I isolates. Eight distinct FKS1 mutations were identified. Isolates from 9 cases with a single FKS1 mutation were clustered in the Clade I tree (0-8 SNP differences). The 2 initial cases were roommates at an LTACH. Six of 7 subsequent cases resided in the same facility as one of the initial cases; 2 stayed in a room immediately after an initial case. The 2 initial cases (A and B, Figure 3) received echinocandin treatment prior to testing culture positive. Two of 7 subsequent cases received pre-culture echinocandins. Conclusion Our investigation identified apparent transmission of C. auris with an FKS1 mutation involving multiple healthcare facilities and highlights the importance of combining public health epidemiologic investigation with WGS analysis. Person-to-person transmission of C. auris with potential echinocandin resistance carries significant infection control implications. Disclosures All Authors: No reported disclosures

Ask AI

Helpful

Bookmark

View Full Paper